Videau Catherine, Hochgeschwender Ute, Kreienkamp Hans Jürgen, Brennan Miles B, Viollet Cécile, Richter Dietmar, Epelbaum Jacques
U.549 INSERM IFR Broca-Sainte Anne, 2 ter rue d'Alésia, 75014 Paris, France.
Naunyn Schmiedebergs Arch Pharmacol. 2003 Jun;367(6):562-71. doi: 10.1007/s00210-003-0758-8. Epub 2003 May 21.
Five somatostatin receptors (sst) have been cloned and mRNAs for the first four (sst1-4) are expressed in many brain regions. In the present work, we compared the distribution of the non-selective ligand [125I]-Tyr0-DTrp8-SRIF14 by autoradiography in 24 brain regions and pituitary in wild type, sst1- to sst4- or SRIF-gene invalidated (KO) mice. [125I]-Tyr0-DTrp8-SRIF14 binding was not significantly modified in sst1 KO mouse brain with the noticeable exception of the substantia nigra and only moderately decreased in pituitary. For sst2 KO mice, a general decrease (>75%) was observed in most regions, with the noticeable exception of the olfactory bulb and CA1 field of the hippocampus. SST3 KO brain displayed a decrease in binding in the external plexiform layer of the olfactory bulb only (-54%). For sst4 KO mice, [125I]-Tyr0-DTrp8-SRIF14 binding levels in the external plexiform (-35%) and glomerular (-39%) layers of the olfactory bulb as well as the hippocampus CA1 field (-68%) were significantly decreased. In SRIF KO mice, a significant increase in binding levels was observed in olfactory bulb, anterior olfactory nucleus, frontal cortex upper layers, lateral septum, CA1 field, zona incerta and lateral hypothalamus, substantia nigra, periaqueductal grey and parabrachial nucleus. Competition with selective ligands (CH275, octreotide or L-779,976, L-796,778, L-803,087, and octreotide or L-817,778, for sst1-5 receptors, respectively) was in accordance with these findings. Moreover, octreotide was still able to compete on residual [125I]-Tyr0-DTrp8-SRIF14 binding sites in sst2 KO pituitary. It is concluded that most [125I]-Tyr0-DTrp8-SRIF14 binding sites in mouse brain and pituitary belong to the sst2 subtype but for the olfactory bulb (sst3 and sst4 receptors), the CA1 of the hippocampus (sst4 receptors) and the pituitary (sst5 and sst1 receptors) in which other subtypes are also expressed. The overall increase in [125I]-Tyr0-DTrp8-SRIF14 binding in SRIF KO mice indicates that SRIF receptors, mostly from the sst2 subtype, are regulated by the endogenous ligand(s).
已克隆出五种生长抑素受体(sst),前四种(sst1 - 4)的信使核糖核酸在许多脑区表达。在本研究中,我们通过放射自显影比较了野生型、sst1至sst4或生长抑素基因无效(KO)小鼠的24个脑区和垂体中[125I]-酪氨酸0 - 色氨酸8 - 生长抑素14([125I]-Tyr0 - DTrp8 - SRIF14)这种非选择性配体的分布情况。在sst1基因敲除小鼠脑中,[125I]-Tyr0 - DTrp8 - SRIF14结合没有显著改变,但黑质是明显的例外,在垂体中仅适度降低。对于sst2基因敲除小鼠,大多数区域观察到普遍下降(>75%),嗅球和海马体CA1区是明显的例外。sst3基因敲除小鼠的脑仅在嗅球外丛状层显示结合减少(-54%)。对于sst4基因敲除小鼠,嗅球外丛状层(-35%)和肾小球层(-39%)以及海马体CA1区(-68%)的[125I]-Tyr0 - DTrp8 - SRIF14结合水平显著降低。在生长抑素基因敲除小鼠中,在嗅球、前嗅核、额叶皮质上层、外侧隔、CA1区、未定带和外侧下丘脑、黑质、导水管周围灰质和臂旁核观察到结合水平显著增加。与选择性配体(分别针对sst1 - 5受体的CH275、奥曲肽或L - 779,976、L - 796,778、L - 803,087以及奥曲肽或L - 817,778)的竞争符合这些发现。此外,奥曲肽仍能与sst2基因敲除垂体中残留的[125I]-Tyr0 - DTrp8 - SRIF14结合位点竞争。得出的结论是,小鼠脑和垂体中的大多数[125I]-Tyr0 - DTrp8 - SRIF14结合位点属于sst2亚型,但嗅球(sst3和sst4受体)、海马体CA1区(sst4受体)和垂体(sst5和sst1受体)也表达其他亚型。生长抑素基因敲除小鼠中[125I]-Tyr0 - DTrp8 - SRIF14结合的总体增加表明,生长抑素受体,主要是sst2亚型,受内源性配体调节。